Advertisement

Topics

Kite Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

08:30 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Kite Pharma, Inc. (Nasdaq:KITE) today announced the closing of its previously announced underwritten public offering of 4,750,000 shares of its common stock at a price to the public of $75.00 per share, as well as the exercise i...

Other Sources for this Article

Kite Pharma, Inc.
Christine Cassiano
SVP, Corporate Communications & Investor Relations
ccassiano@kitepharma.com
or
Greg Mann
VP, Investor Relations
gmann@kitepharma.com

NEXT ARTICLE

More From BioPortfolio on "Kite Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares"

Advertisement
Quick Search
Advertisement
Advertisement